CDKN2A and neoplasm: Arf can inhibit the transformation of MEFs in the presence of MDM2 inhibitor (120) by directly binding to the MDM2 protein and inhibiting the ubiquitination of TP53, thereby stabilizing this tumor-suppressor protein [115,116,117,118].